LAB.00028 Blood-based Biomarker Tests for Multiple Sclerosis

This policy addresses blood-based biomarker tests for multiple sclerosis (MS), including use for diagnosis, prognosis, or disease management. Anthem considers these tests investigational and not medically necessary; they are not covered for any indication. Non-coverage applies to all clinical scenarios (including MS and clinically isolated syndrome) and may be reported with CPT/HCPCS codes 81599, 83884, 84999 and ICD-10 codes G35.A, G35.D, G37.9.

"Blood-based biomarker tests for multiple sclerosis are consideredinvestigational and not medically necessaryfor all uses."

Sign up to see full coverage criteria, indications, and limitations.